Value Analysis Overview

Anti-migration Assurance Program

The unique anti-migration technology aids in reducing the risk of reinterventions. The fully covered atraumatic anchoring fins securely hold the device within the duct.

  • Reported migration rate average of 0.2%1
  • GORE® VIABIL® Short Wire Biliary Endoprosthesis is the only fully covered metal stent with anti-migration technology proven to reduce the risk of reintervention
  • Replacement device of identical dimensions for use with the patient whose device migrates within one year post implantation

The extremely low migration rates of the GORE® VIABIL® Short Wire Biliary Endoprosthesis help me limit patients’ risks and keep their quality of life and satisfaction with their outcomes as high as I’m able, and I’m pleased to see that performance now backed by Gore’s cost-reducing Anti-Migration Assurance Program.

Todd Baron, MD, UNC Hospitals GI Medicine Clinic

Contact your ConMed Territory Manager for details of the program. ConMed distributes the GORE® VIABIL® Short Wire Biliary Endoprothesis.

Program Details

null

View Program Details

Anti-Migration Assurance Program

532 KB

  1. W. L. Gore & Associates, Inc. Migration Summary for GORE® VIABIL® Biliary Endoprosthesis and BOSTON SCIENTIFIC WALLFLEX Biliary RX Fully Covered Stent. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2017. [Literature Summary]. AW0010-EN3.